Peng Dai
Taiyuan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
LINC01012 Drives Hepatitis B-Related Hepatocellular Carcinoma Progression Through HNRNPL-Mediated Stabilization of Serine/Threonine-Protein Kinase-S.
Journal: Journal of medical virology
Published: March 19, 2026
Integrative multi-omics profiling reveals coordinated immunometabolic reprogramming and host-microbiome interactions in acute pancreatitis.
Journal: Frontiers in immunology
Published: March 12, 2026
MiR-4725-3p acts as an oncogene and prognostic biomarker in hepatocellular carcinoma.
Journal: World journal of surgical oncology
Published: February 03, 2026
MiR-5100 promotes the malignant phenotype of triple-negative breast cancer cells by targeting SMAD4 and predicts poor prognosis.
Journal: World journal of surgical oncology
Published: January 09, 2026
LncRNA FRMD6-AS2 inhibits the malignant progression of bladder cancer by targeting miR-1260a.
Journal: World journal of surgical oncology
Published: September 23, 2025
Molecular Mechanism of Long Non-Coding RNAs in Ovarian Cancer: CASC19 Regulates the Malignant Progression of Ovarian Cancer through miR-761/CBX2 Axis.
Journal: Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer
Published: September 08, 2025
miR-4326 predicts adverse outcomes of triple-negative breast cancer and regulates cell growth and motility through modulating MED13.
Journal: World journal of surgical oncology
Published: August 04, 2025
Metabolic reprogramming in hepatocellular carcinoma: an integrated omics study of lipid pathways and their diagnostic potential.
Journal: Journal of translational medicine
Published: February 04, 2025
Hsa-circVIM regulates breast cancer tumor progression and tamoxifen sensitivity by sponging miR-1294 in hormone receptor-positive breast cancer cells.
Journal: Discover oncology
Published: January 18, 2025
Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis.
Journal: Aging
Published: May 24, 2023
Gut microbial signatures of patients with primary hepatocellular carcinoma and their healthy first-degree relatives.
Journal: Journal of applied microbiology
Published: April 28, 2023
Last Updated: 09/26/2026